Evidence map›Paper›PMID 29065666›Full record

ArticleJournal of healthcare engineering2017

Low-Grade Glioma Segmentation Based on CNN with Fully Connected CRF.

Zeju Li, Yuanyuan Wang, Jinhua Yu, Zhifeng Shi, Yi Guo, Liang Chen, Ying Mao

Abstract read
In one paragraph

Article in Journal of healthcare engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Zeju LiDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Yuanyuan WangDepartment of Electronic Engineering, Fudan University, Shanghai, China.ORCID 0000-0003-1984-1136
Jinhua YuDepartment of Electronic Engineering, Fudan University, Shanghai, China.ORCID 0000-0002-0654-6034
Zhifeng ShiDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Yi GuoDepartment of Electronic Engineering, Fudan University, Shanghai, China.
Liang ChenDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Ying MaoDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work proposed a novel automatic three-dimensional (3D) magnetic resonance imaging (MRI) segmentation method which would be widely used in the clinical diagnosis of the most common and aggressive brain tumor, namely, glioma. The method combined a multipathway convolutional neural network (CNN) and fully connected conditional random field (CRF). Firstly, 3D information was introduced into the CNN which makes more accurate recognition of glioma with low contrast. Then, fully connected CRF was added as a postprocessing step which purposed more delicate delineation of glioma boundary. The method was applied to T2flair MRI images of 160 low-grade glioma patients. With 59 cases of data training and manual segmentation as the ground truth, the Dice similarity coefficient (DSC) of our method was 0.85 for the test set of 101 MRI images. The results of our method were better than those of another state-of-the-art CNN method, which gained the DSC of 0.76 for the same dataset. It proved that our method could produce better results for the segmentation of low-grade gliomas.

Indexed as

Neural Networks, ComputerBrain NeoplasmsFemaleGliomaHumansImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance ImagingMale

Identifiers

PMID29065666
PMCPMC5485483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.